Product Information
LIDOCAINE HCL 2% 100 MG/5 ML is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.3487 per ML under NDC 31722011834. Its NADAC has been published 57 times since May 7, 2025.
FDA first approved this application on Nov 8, 2021. Its Orange Book therapeutic-equivalence code is AP.
Strength
20 mg/mL
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722011834
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL
Effective Date
7/22/2026
Active Ingredients
LIDOCAINE HYDROCHLORIDE ANHYDROUSApproval Type
Generic (ANDA)
FDA Application
ANDA214339FDA Approved
11/8/2021
TE Code
AP
On Market Since
11/8/2021
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE HCL 2% 100 MG/5 ML has been published 57 times since May 7, 2025, and over the history we have for it it has declined 12.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3487 per ML |
|---|---|
| All-time high | $0.4109 (Feb 11, 2026) |
| All-time low | $0.3487 (Jul 22, 2026) |
| 52-week high | $0.4109 |
| 52-week low | $0.3487 |
| Median price | $0.3747 |
| Average price | $0.3790 |
| Largest weekly change | -5.6% (Mar 18, 2026) |
| Weeks tracked | 57 |
| Tracking since | May 7, 2025 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 78% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE HCL 2% 100 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE HCL 2% 100 MG/5 ML, manufactured by Camber Pharmaceuticals Inc., is $0.3487 per ML (NDC 31722011834), effective Sep 30, 2026.
How has the price of LIDOCAINE HCL 2% 100 MG/5 ML changed over time?
Over the history we have for it, the NADAC for LIDOCAINE HCL 2% 100 MG/5 ML has declined 12.8%. It has been tracked across 57 weekly CMS publications since May 7, 2025.
What are the highest and lowest recorded NADAC prices for LIDOCAINE HCL 2% 100 MG/5 ML?
Since May 7, 2025, the NADAC for LIDOCAINE HCL 2% 100 MG/5 ML has ranged from a low of $0.3487 (Jul 22, 2026) to a high of $0.4109 (Feb 11, 2026), with a median of $0.3747 per ML.
Are there cheaper alternatives to LIDOCAINE HCL 2% 100 MG/5 ML?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIDOCAINE HCL 2% VIAL, is $0.0762 per ML — about 78% below LIDOCAINE HCL 2% 100 MG/5 ML.
Who manufactures LIDOCAINE HCL 2% 100 MG/5 ML?
LIDOCAINE HCL 2% 100 MG/5 ML (NDC 31722011834) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.